Wifugart IV infusion 400mg, manufactured by Argenix Japan, contains Efgartigimod alfa (genetical recombination). This injectable drug (YJ code: 6399430A1029) is supplied as 400mg in 20mL per bottle. It is used to treat generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
Wifugart IV infusion 400mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →